احدث جهاز تحت التجربة بتقنية الانابيب والشرايح الدهبية النانوية وله مستقبل واعد يغنى الاطباء من طلب عينات كثيرة للمرضى فى المختبرات الجهاز له خاصية الكشف عن 17 نوع من مرض السرطان وغيره
Table 1. Demographic Characteristics of Patients and Healthy Controls in the Current Study
patients controls
group n age ± SDa male, n (%) smoker, n (%) n age ± SDa male, n (%) smoker, n (%)
lung cancer (LC) 45 67 ± 09 23 (51%) 44 (98%) 23 56 ± 14 12 (52%) 12 (52%)
colorectal cancer (CRC) 71 66 ± 10 42 (59%) 09 (11%) 89 60 ± 14 67 (75%) 09 (13%)
head and neck cancer (HNC) 22 62 ± 12 19 (86%) 13 (59%) 19 50 ± 12 06 (32%) 05 (25%)
ovarian cancer (OC) 48 51 ± 11 00 (00%) 00 (00%) 48 47 ± 09 00 (00%) 00 (0%)
bladder cancer (BC) 73 69 ± 11 68 (93%) 53 (68%) 35 66 ± 12 31 (88%) 25 (71%)
prostate cancer (PC) 11 66 ± 08 11(100%) 05 (45%)
kidney cancer (KC) 33 65 ± 13 22 (66%) 15 (45%)
gastric cancer (GC) 99 63 ± 12 57 (58%) 26 (27%) 155 57 ± 15 55 (34%) 23 (15%)
Crohn’s disease (CD) 41 38 ± 12 23 (56%) 20 (50%) 44 41 ± 02 28 (60%) 15 (35%)
ulcerative colitis (UC) 37 41 ± 16 20 (56%) 16 (43%)
irritable bowel syndrome (IBS) 27 38 ± 13 08 (32%) 08 (30%)
idiopathic Parkinson’s (IPD) 44 65 ± 14 23 (53%) 07 (15%) 37 62 ± 12 19 (51%) 09 (24%)
atypical Parkinsonism (PDISM) 16 67 ± 08 07 (44%) 06 (35%)
multiple sclerosis (MS) 118 38 ± 10 42 (36%) 38 (32%) 44 39 ± 11 17 (38%) 15 (34%)
pulmonary hypertension (PAH) 22 48 ± 12 06 (27%) 12 (54%) 23 38 ± 08 10 (43%) 10 (43%)
pre-eclampsia toxemia (PET) 24 30 ± 06 00 (00%) 00 (00%) 47 29 ± 04 00 (00%) 00 (00%)
chronic kidney disease (CKD) 82 65 ± 12 52 (64%) 24 (29%) 27 46 ± 02 12 (45%) 11 (40%)
total 813 55 ± 10 423 (52%) 296 (36%) 591 52 ± 08 257 (43%) 134 (23%)
http://pubs.acs.org/doi/full/10.1021/acsnano.6b04930
-
http://pubs.acs.org/doi/full/10.1021/acsnano.6b04930http://pubs.acs.org/doi/full/10.1021/acsnano.6b04930
تستطيع المشاركة هنا والرد على الموضوع ومشاركة رأيك عبر حسابك في الفيس بوك